Yıldız Pehlivan D, Yıldız H, Kaya G. Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study. Eur J Ther [Internet]. 2025 Feb. 28 [cited 2025 Mar. 7];31(1):1-10. Available from: https://eurjther.com/index.php/home/article/view/2520